Stop Pills That Kill Act
- Sponsor
- Sen. Grassley, Chuck [R-IA]
- Committees
- Judiciary Committee (primary)
- Last action
- Oct 30, 2025
Bottom line
The bill aims to strengthen federal law enforcement's ability to combat the illicit trade of counterfeit fentanyl and methamphetamine through updated legal definitions, strategic planning, and enhanced data reporting.
What it actually does
This bill amends the Controlled Substances Act to specifically include fentanyl, its analogues, and counterfeit substances in prohibited acts related to drug manufacturing and distribution. It also mandates the Drug Enforcement Administration (DEA) to create a comprehensive operation and response plan for counterfeit fentanyl or methamphetamine substances, including enhanced education and prevention efforts. Furthermore, it requires the Attorney General to submit annual reports to Congress on data related to the seizure, prosecution, and prevention of these counterfeit substances.
Proponents argue
Supporters argue that this legislation is a critical step in addressing the ongoing opioid crisis by providing law enforcement with clearer tools to prosecute those who traffic in deadly counterfeit drugs, particularly fentanyl. They emphasize the importance of the mandated DEA plan for proactive enforcement, targeted prevention, and education, especially for youth, and the annual reporting requirement for ensuring accountability and informing future policy decisions.
Opponents contend
Critics may contend that while the intent is laudable, the bill primarily focuses on criminalization and enforcement without adequately addressing the root causes of addiction or providing sufficient resources for treatment and harm reduction. Some might argue that existing laws are already sufficient, and that further expanding prohibited acts could lead to increased incarceration rates without effectively deterring high-level traffickers, or that the administrative burdens on agencies could divert resources from other critical areas.
The bill is concise and can be read quickly, allowing for a thorough understanding of its provisions within a short timeframe.
Section 2
Defining Counterfeit Fentanyl or Methamphetamine Substances
This section establishes a new definition for 'counterfeit fentanyl or methamphetamine substance.' It specifies that such a substance must contain fentanyl, a fentanyl analogue, or methamphetamine, and be marketed, sold, or falsely bear the trademark or identifying mark of another product. This definition is crucial for the bill's subsequent enforcement provisions.
Supporters argue
Supporters argue that a precise definition is essential for law enforcement to effectively combat the proliferation of dangerous counterfeit drugs, ensuring that those who intentionally misrepresent these substances face appropriate legal consequences.
Critics contend
Critics might express concerns that the definition, while seemingly clear, could lead to challenges in proving intent or distinguishing between truly 'counterfeit' substances and other illicitly manufactured drugs, potentially broadening the scope of criminalization in unintended ways.
Tradeoffs
This provision aims to provide legal clarity for enforcement but must balance the need for specificity with the dynamic nature of illicit drug markets and the potential for broad application.
Section 3
Expanding Prohibited Acts in the Controlled Substances Act
This section amends Section 403(d)(2) of the Controlled Substances Act to explicitly include 'fentanyl, an analogue of fentanyl, or a counterfeit substance' in the list of prohibited acts. This means that engaging in certain activities, such as using a communication facility to commit a felony involving these substances, will now fall under the expanded scope of federal drug laws.
Section 4
DEA Comprehensive Operation and Response Plan
This section mandates the Administrator of the Drug Enforcement Administration (DEA) to establish and implement a comprehensive operation and response plan within 180 days of the bill's enactment. The plan must include strategies for federal law enforcement to investigate and seize counterfeit fentanyl or methamphetamine substances, increase education and prevention efforts (especially tailored for youth and teens), and audit current public awareness campaigns like 'One Pill Can Kill' to improve their effectiveness.
Section 5
Annual Report to Congress on Counterfeit Substances
This section requires the Attorney General, in consultation with the DEA and the Office of National Drug Control Policy (ONDCP), to submit an annual report to Congress. The report must include comprehensive data on the aggregate number of counterfeit fentanyl or methamphetamine substances seized, a breakdown of those in pill form and their illicit contents, seizure locations and times, and data on charges, convictions, and sentences related to these substances. It also requires details on prevention measures undertaken by the agencies.